跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13 条关于
“IL23p19”
全部
13
临床试验
0
药物
4
机构
0
资讯
9
去年
Anti-IL23p19 Therapies Transform IBD Treatment Landscape Ahead of ECCO 2025
去年
Gastroenterology Update: Cendakimab, Mirikizumab Data, Cologuard Plus Approval, and GLP-1 RA Risks
去年
Lilly's Omvoh and J&J's Tremfya Show Promise in Crohn's Disease Phase III Trials
上个月
Xencor Reports Q2 2026 Results and Advances XmAb819, XmAb541 and XmAb942 Clinical Programs
9个月前
China Approves First Domestic IL-23p19 Antibody for Psoriasis Treatment
去年
Spyre Therapeutics Accelerates SPY003 (IL-23p19) Clinical Timelines Based on Preclinical Data
2年前
FDA Approves Mirikizumab (Omvoh) as First IL-23p19 Antagonist for Ulcerative Colitis
去年
Innovent's Picankibart NDA Accepted in China for Plaque Psoriasis Treatment
去年
Oruka Therapeutics Initiates Phase 1 Trial of ORKA-001, a Novel IL-23p19 Antibody